The management of hyperkalaemia in the emergency department

P Ahee, AV Crowe - Emergency Medicine Journal, 2000 - emj.bmj.com
Life threatening hyperkalaemia (> 7.0 mmol/l ) is commonly associated with acute renal failure.
Moderate hyperkalaemia ( 6.1–6.9 mmol/l ) is also common and well tolerated in patients …

A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114

AS Crystal, BI Giasson, A Crowe… - Journal of …, 2003 - Wiley Online Library
Proteinaceous inclusions with amyloidogenic properties are a common link between many
neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. …

Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau

W Li, JB Sperry, A Crowe… - Journal of …, 2009 - Wiley Online Library
Tau is a microtubule‐associated protein that promotes microtubule assembly and stability.
In Alzheimer’s disease and related tauopathies, tau fibrillizes and aggregates into …

Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo

GJ Kemp, AV Crowe, HKI Anijeet… - Nephrology Dialysis …, 2004 - academic.oup.com
Background. Muscle dysfunction, which contributes to morbidity in patients on haemodialysis,
has several manifestations and a number of possible causes. We applied the non-invasive …

[HTML][HTML] Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation

A Crowe, MJ James, VMY Lee, AB Smith… - Journal of Biological …, 2013 - ASBMB
Alzheimer disease and several other neurodegenerative disorders are characterized by the
accumulation of intraneuronal fibrils comprised of the protein Tau. Tau is normally a soluble …

Characterization of brain-penetrant pyrimidine-containing molecules with differential microtubule-stabilizing activities developed as potential therapeutic agents for …

…, AS Cornec, Y Yao, M James, A Crowe… - … of Pharmacology and …, 2016 - ASPET
The microtubule (MT)–stabilizing protein tau disengages from MTs and forms intracellular
inclusions known as neurofibrillary tangles in Alzheimer’s disease and related tauopathies. …

Renal transplantation following renal failure due to urological disorders.

A Crowe, HS Cairns, S Wood, CJ Rudge… - … official publication of …, 1998 - academic.oup.com
BACKGROUND: Renal allograft outcome, during an 8 year period (1985-1992), has been
assessed in 56 renal transplants performed in 55 patients who had end-stage renal failure as …

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

A Crowe, C Ballatore, E Hyde, JQ Trojanowski… - Biochemical and …, 2007 - Elsevier
A library of ∼51,000 compounds was interrogated by high throughput screening (HTS) using
a heparin-induced tau fibrillization assay. HTS was conducted with bacterially expressed …

Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening

A Crowe, W Huang, C Ballatore, RL Johnson… - Biochemistry, 2009 - ACS Publications
Inclusions comprised of fibrils of the microtubule- (MT-) associated protein tau are found in
the brains of those with Alzheimer’s disease (AD) and other neurodegenerative tauopathies. …

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors

KR Brunden, C Ballatore, A Crowe, AB Smith III… - Experimental …, 2010 - Elsevier
The microtubule-associated protein tau forms insoluble filaments that deposit as neurofibrillary
tangles (NFTs) in the brains of those with Alzheimer's disease (AD) and other related …